ScripEstablished only last year, ABL Bio Inc. may probably be a rookie, but it is already seen as a leading bispecific antibody firm in South Korea thanks to its strong pipeline and platform technology tha
ScripSEOUL – As the number of biosimilar products to hit the South Korean market is set to increase ever more rapidly amid rising interest in the space and years of aggressive investment by domestic firms,
ScripSEOUL - South Korea's Ministry of Food and Drug Safety (MFDS) has granted approval for Samsung Bioepis Co. Ltd. to launch SB4, its biosimilar version of Amgen Inc. 's rheumatoid arthritis block
ScripSEOUL – The panelists believed the biopharmaceutical market will shift away from the U.S. and EU to Asia in the longer term, and expected more than 65% of the global biopharma market to be in Asian te